V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007777 | 190002036 | null | null | null | null | 2018-08-07 | EW EuroEwing 2012 Arm A VIDE | null | null | ECX | 100346001 |
| 190007780 | 190002038 | 1.77 | 61.4 | Palliative (P) | 2018-04-03 | 2018-04-06 | FLUOROURACIL + OXALIPLATIN | 02 | N | GEMCITABINE | 101755639 |
| 190007782 | 190002039 | null | null | null | null | 2016-06-07 | GEMCARBO | null | null | LANREOTIDE | 101253386 |
| 190007788 | 190002041 | 1.78 | null | 03 | 2015-07-05 | 2015-07-06 | Dox + HD Mtx (post PAM) | 02 | N | CISPLATIN + FLUOROURACIL | 100589665 |
| 190007795 | 190002044 | null | null | null | null | 2019-11-28 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101076805 |
| 190007797 | 190002045 | 1.62 | 43.5 | Neo-adjuvant (N) | 2019-12-06 | 2019-12-13 | ECX | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101527986 |
| 190007802 | 190002047 | 0 | 48.8 | Curative (C) | 2016-05-02 | 2016-05-11 | Carboplatin AUC 6 - 10 | 02 | Y | CETUXIMAB | 100150633 |
| 190007804 | 190002049 | 1.67 | 41.4 | Curative (C) | 2018-06-07 | 2018-06-21 | CISPLATIN + RT | 02 | N | CISPLATIN | 101659358 |
| 190007810 | 190002051 | null | null | null | null | 2017-11-13 | ECX | null | null | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 101118687 |
| 190007814 | 190002052 | null | null | null | null | 2019-02-11 | GEMCITABINE + NAB PACLITAXEL | null | null | BLEOMYCIN + CISPLATIN + VINCRISTINE | 100097467 |
| 190007820 | 190002055 | 1.81 | 45.3 | Neo-adjuvant (N) | 2016-08-19 | 2016-09-02 | CARBOPLATIN + PACLITAXEL | N | N | FLUOROURACIL + OXALIPLATIN | 101239046 |
| 190007821 | 190002056 | 1.61 | 74.4 | Neo-adjuvant (N) | 2018-07-01 | 2018-07-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101038385 |
| 190007823 | 190002057 | null | null | null | null | 2016-09-12 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 101112359 |
| 190007826 | 190002059 | null | null | null | null | 2019-12-21 | ECX | null | null | BLEOMYCIN + CISPLATIN + VINCRISTINE | 100569318 |
| 190007830 | 190002061 | 1.63 | 79 | Neo-adjuvant (N) | null | 2018-09-14 | Carboplatin + Etoposide IV 3 day | N | N | CARBOPLATIN + ETOPOSIDE | 100221926 |
| 190007835 | 190002062 | null | null | null | null | 2016-04-14 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100801007 |
| 190007846 | 190002067 | 1.67 | 52 | Curative (C) | 2013-11-27 | 2013-12-01 | Oxaliplatin + Modified de Gramont | 2 | N | CAPECITABINE + OXALIPLATIN | 100489791 |
| 190007849 | 190002069 | null | null | null | null | 2019-05-14 | OCTREOTIDE | null | null | CETUXIMAB + RT | 100476814 |
| 190007854 | 190002071 | null | null | null | null | 2019-11-07 | EURAMOS TRIAL | null | null | CISPLATIN + RT | 100039545 |
| 190007860 | 190002075 | 1.77 | 101.2 | Curative (C) | 2017-11-29 | 2017-11-29 | Cisplatin+Gemcitabine (gallbladder) | N | Y | CISPLATIN + GEMCITABINE | 100770308 |
| 190007861 | 190002076 | null | null | null | null | 2016-07-07 | DOXORUBICIN | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100843508 |
| 190007868 | 190002080 | null | null | null | null | 2019-03-08 | CAPECITABINE + TEMOZOLOMIDE | null | null | FCIST | 101667864 |
| 190007871 | 190002081 | null | null | null | null | 2016-02-17 | Cisplatin 7 day | null | null | CISPLATIN | 100528805 |
| 190007874 | 190002082 | null | null | null | null | 2018-07-26 | MPT | null | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100105118 |
| 190007880 | 190002084 | 0 | 107 | Palliative (P) | 2019-03-18 | 2019-03-18 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | GEMCITABINE + PACLITAXEL | 100135843 |
| 190007887 | 190002085 | null | 57.6 | 03 | 2016-05-22 | 2016-05-29 | EURAMOS TRIAL | Y | N | EW EUROEWING 2012 ARM A VIDE | 100553113 |
| 190007889 | 190002086 | null | null | null | null | 2019-11-14 | EOX | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100403325 |
| 190007898 | 190002090 | null | null | null | null | 2017-02-13 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100425629 |
| 190007900 | 190002091 | 0 | 60 | Curative (C) | 2018-09-13 | 2018-09-27 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CISPLATIN | 101088727 |
| 190007905 | 190002093 | 1.8 | 68.9 | Adjuvant (A) | 2017-08-05 | 2017-08-30 | VDC | 02 | N | CAPECITABINE + OXALIPLATIN | 100139204 |
| 190007906 | 190002094 | null | null | null | null | 2017-06-14 | Trial Unspecified | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101266532 |
| 190007909 | 190002096 | null | null | null | null | 2016-03-25 | LUTETIUM-177 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100366927 |
| 190007914 | 190002099 | 1.73 | 61.2 | Palliative (P) | 2016-03-26 | 2016-04-01 | Cisplatin 7 day | N | N | CISPLATIN | 100957670 |
| 190007918 | 190002100 | 1.63 | 50.55 | Curative (C) | 2022-05-03 | 2022-05-03 | Cisplatin 7 day | 02 | Y | CISPLATIN | 101115604 |
| 190007922 | 190002103 | null | null | null | null | 2016-08-18 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100605937 |
| 190007924 | 190002104 | null | null | null | null | 2016-03-17 | Carboplatin + Etoposide IV 3 day | null | null | CARBOPLATIN + ETOPOSIDE | 101159397 |
| 190007926 | 190002105 | 1.68 | 99 | Palliative (P) | 2018-02-03 | 2018-02-05 | Oxaliplatin + Modified de Gramont | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101129410 |
| 190007934 | 190002106 | null | null | null | null | 2017-09-15 | CHOP R - 21 days | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101185266 |
| 190007938 | 190002108 | null | null | null | null | 2017-12-20 | null | null | null | CAPECITABINE + TEMOZOLOMIDE | 101605510 |
| 190007939 | 190002109 | 1.72 | 82.7 | null | 2017-07-27 | 2017-07-27 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100907136 |
| 190007941 | 190002111 | null | null | null | null | 2019-03-30 | FEC | null | null | GEMCITABINE | 100353331 |
| 190007945 | 190002112 | null | null | null | null | 2012-11-14 | EOX | null | null | OXALIPLATIN + RALTITREXED | 100937897 |
| 190007959 | 190002118 | 1.55 | 63 | Palliative (P) | 2017-04-19 | 2017-04-19 | Dox + HD Mtx (post PAM) | 02 | N | OCTREOTIDE | 100937043 |
| 190007962 | 190002120 | 1.53 | 59 | Curative (C) | 2017-11-07 | 2017-11-15 | Cisplatin 7 day | 02 | N | CISPLATIN | 101116804 |
| 190007970 | 190002125 | null | null | null | null | 2017-12-22 | ECX | null | null | OCTREOTIDE | 101789340 |
| 190007972 | 190002126 | 1.61 | 83.6 | Palliative (P) | 2020-07-19 | 2020-08-04 | null | 02 | N | CAPECITABINE + OXALIPLATIN | 101180279 |
| 190007975 | 190002127 | null | null | null | null | 2017-03-23 | LUTETIUM-177 | null | null | CARBOPLATIN | 100532757 |
| 190007976 | 190002128 | 1.7 | 49.6 | Curative (C) | 2019-12-10 | 2019-12-15 | CNS ATRT Doxorubicin + GCSF | 02 | null | MITOMYCIN | 101823666 |
| 190007978 | 190002129 | null | null | null | null | 2018-10-19 | VIDE | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101237920 |
| 190007982 | 190002130 | 1.68 | 78.6 | Curative (C) | 2019-01-09 | 2019-01-10 | Carboplatin + Paclitaxel (3 weekly) | Y | N | CARBOPLATIN + PACLITAXEL | 100965767 |